Association Between Antinuclear Antibodies and interstitial lung Diseases in patients with Systemic Lupus Erythematosus
DeifAllah, O., Hamed, W., Ismail, M. (2019). Association Between Antinuclear Antibodies and interstitial lung Diseases in patients with Systemic Lupus Erythematosus. EKB Journal Management System, 23(3), 168-175. doi: 10.21608/smj.2019.13890.1001
Osama sayed DeifAllah; Walaa Elsayed Hamed; Mohamed Ali Ismail. "Association Between Antinuclear Antibodies and interstitial lung Diseases in patients with Systemic Lupus Erythematosus". EKB Journal Management System, 23, 3, 2019, 168-175. doi: 10.21608/smj.2019.13890.1001
DeifAllah, O., Hamed, W., Ismail, M. (2019). 'Association Between Antinuclear Antibodies and interstitial lung Diseases in patients with Systemic Lupus Erythematosus', EKB Journal Management System, 23(3), pp. 168-175. doi: 10.21608/smj.2019.13890.1001
DeifAllah, O., Hamed, W., Ismail, M. Association Between Antinuclear Antibodies and interstitial lung Diseases in patients with Systemic Lupus Erythematosus. EKB Journal Management System, 2019; 23(3): 168-175. doi: 10.21608/smj.2019.13890.1001

Association Between Antinuclear Antibodies and interstitial lung Diseases in patients with Systemic Lupus Erythematosus

Sohag Medical Journal
Article 31, Volume 23, Issue 3, July 2019, Page 168-175  XML PDF (463.83 K)
Document Type: Original Article
DOI: 10.21608/smj.2019.13890.1001
View on SCiNiTO View on SCiNiTO
Authors
Osama sayed DeifAllah1; Walaa Elsayed Hamed email 2; Mohamed Ali Ismail1
1Rheumatology & rehabilitation department, faculty of medicine, Sohag University, Sohag, Egypt
2Rheumatology & rehabilitation department, faculty of medicine, Sohag University, Sohag, Egypt
Abstract
Abstract
Introduction: Systemic Lupus Erythematosus (SLE) is adisease primarily affecting women in their child-bearing years. SLE can affect any component of the respiratory system and manifest with pleuritis (with or without effusion), interstitial lung disease (ILD), alveolar hemorrhage, diaphragmatic weakness, pulmonary hypertension, airways disease, or pulmonary embolism. ILD occurs with a lower frequency in SLE compared with other connective tissue disease (CTD) subtypes. It is not known whether SLE-ILD differs from ILD in other CTD subtypes.
Aim of the work: estimate the possible relationship between interstitial lung diseases and different antinuclear antibodies among patients with systemic lupus erythematosus.
Patients and Methods: Cross sectional clinical study. A total of 100 SLE patients attending to Sohag University Hospitals will be included in the study. Patients included in this study will be classified as SLE patients according to either the 2012 SLICC criteria or the new 2017 ACR/EULAR SLE classification criteria.
Results: ANA (antinuclear antibody) positivity, chest manifestations like (cough, dyspnea, expectoration, fever&hemoptysis) are predictive variates for SLE-ILD.
Conclusion: We observed a population of SLE-ILD and concluded that ANA (antinuclear antibody) positivity, chest manifestations like (cough, dyspnea, expectoration, fever&hemoptysis) are predictive variates for SLE-ILD. Also ANAIF speckled pattern has specificity to SLE-ILD and AntiSS-A/Ro52KD antibody is more specific to SLE-ILD. We recom‌mend HRCT and PFT scan in these SLE patients.
Keywords
Key words: ANA; ILD; SLE
Supplementary Files
Statistics
Article View: 259
PDF Download: 459